C4 Therapeutics Inc
Sector: Manufacturing
Industry: Pharmaceutical Products
1.79
-0.06
(-2.99%)
Volume:
207,713
52 week range:
1.79 - 8.29
Market Cap:
130.621M
Company Description:
C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins. Its lead product candidate is an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting multiple myeloma and non-Hodgkin lymphomas. The company was incorporated in 2015 and is headquartered in Watertown, Massachusetts.